Entity Details

Primary name NEP_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP08473
EntryNameNEP_HUMAN
FullNameNeprilysin
TaxID9606
Evidenceevidence at protein level
Length750
SequenceStatuscomplete
DateCreated1988-08-01
DateModified2021-06-02

Ontological Relatives

GenesMME

GO terms

Show/Hide Table
GOName
GO:0001786 phosphatidylserine binding
GO:0001822 kidney development
GO:0001890 placenta development
GO:0002003 angiotensin maturation
GO:0004175 endopeptidase activity
GO:0004222 metalloendopeptidase activity
GO:0005737 cytoplasm
GO:0005769 early endosome
GO:0005802 trans-Golgi network
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0005903 brush border
GO:0005925 focal adhesion
GO:0006508 proteolysis
GO:0006518 peptide metabolic process
GO:0007568 aging
GO:0007611 learning or memory
GO:0008021 synaptic vesicle
GO:0008237 metallopeptidase activity
GO:0008238 exopeptidase activity
GO:0008270 zinc ion binding
GO:0009986 cell surface
GO:0016021 integral component of membrane
GO:0016485 protein processing
GO:0019233 sensory perception of pain
GO:0030324 lung development
GO:0030424 axon
GO:0030425 dendrite
GO:0030667 secretory granule membrane
GO:0031410 cytoplasmic vesicle
GO:0042277 peptide binding
GO:0042803 protein homodimerization activity
GO:0043025 neuronal cell body
GO:0043312 neutrophil degranulation
GO:0044306 neuron projection terminus
GO:0045121 membrane raft
GO:0045202 synapse
GO:0046449 creatinine metabolic process
GO:0050435 amyloid-beta metabolic process
GO:0050769 positive regulation of neurogenesis
GO:0061837 neuropeptide processing
GO:0070012 oligopeptidase activity
GO:0070062 extracellular exosome
GO:0071345 cellular response to cytokine stimulus
GO:0071492 cellular response to UV-A
GO:0071493 cellular response to UV-B
GO:0090399 replicative senescence
GO:0097242 amyloid-beta clearance
GO:0098793 presynapse
GO:0150094 amyloid-beta clearance by cellular catabolic process
GO:1900273 positive regulation of long-term synaptic potentiation
GO:1901612 cardiolipin binding

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR000718 Peptidase M13FamilyFamily
IPR008753 Peptidase M13, N-terminal domainDomainDomain
IPR018497 Peptidase M13, C-terminal domainDomainDomain
IPR024079 Metallopeptidase, catalytic domain superfamilyFamilyHomologous superfamily
IPR029727 NeprilysinFamilyFamily
IPR042089 Peptidase M13, domain 2FamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
617017 OMIMCharcot-Marie-Tooth disease 2T (CMT2T)An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. The disease is caused by variants affecting the gene represented in this entry.
617018 OMIMSpinocerebellar ataxia 43 (SCA43)A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA43 is a slowly progressive, autosomal dominant form. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00616 CandoxatrilDrugbanksmall molecule
DB00886 OmapatrilatDrugbanksmall molecule
DB02062 N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]AlanineDrugbanksmall molecule
DB02557 PhosphoramidonDrugbanksmall molecule
DB02558 N-(3-Phenyl-2-Sulfanylpropanoyl)PhenylalanylalanineDrugbanksmall molecule
DB02597 [2(R,S)-2-Sulfanylheptanoyl]-Phe-AlaDrugbanksmall molecule
DB05796 DaglutrilDrugbanksmall molecule
DB06655 LiraglutideDrugbankbiotech
DB08575 2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUMDrugbanksmall molecule
DB08626 ThiorphanDrugbanksmall molecule
DB09292 SacubitrilDrugbanksmall molecule
DB11623 CandoxatrilatDrugbanksmall molecule
DB13928 SemaglutideDrugbanksmall molecule